Rhythm and Conduction Disorders in Patients Receiving Ibrutinib
Aim. Early diagnosis and treatment of rhythm and conduction disorders in patients receiving ibrutinib. Materials & Methods. The trial included 206 patients with indications for ibrutinib, 193 of them are at different stages of treatment from 1.5 to 51 months. The trial enrolled the patients wit...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Practical Medicine Publishing House
2019-03-01
|
| Series: | Kliničeskaâ onkogematologiâ |
| Subjects: | |
| Online Access: |
http://bloodjournal.ru/wp-content/uploads/2019/03/13.pdf
|